Terms: = Bone cancer AND TSC1, KIAA0243, 7248, ENSG00000165699, TSC, MGC86987, LAM, hamartin
51 results:
1. Genetic disorders and insulinoma/glucagonoma.
Marini F; Giusti F; Brandi ML
Endocr Relat Cancer; 2024 May; 31(5):. PubMed ID: 38552306
[TBL] [Abstract] [Full Text] [Related]
2. Long Noncoding RNA Gpr137b-ps Promotes Advanced Atherosclerosis via the Regulation of Autophagy in Macrophages.
Qu W; Zhou X; Jiang X; Xie X; Xu K; Gu X; Na R; Piao M; Xi X; Sun N; Wang X; Peng X; Xu J; Tian J; Zhang J; Guo J; Zhang M; Zhang Y; Pan Z; Wang K; Yu B; Sun B; Li S; Tian J
Arterioscler Thromb Vasc Biol; 2023 Nov; 43(11):e468-e489. PubMed ID: 37767704
[TBL] [Abstract] [Full Text] [Related]
3.
Cho CY; Kang SH; Kim BC; Kim TK; Kim JH; Kim M; Sohn Y; Jung HS
Mol Med Rep; 2023 Oct; 28(4):. PubMed ID: 37594079
[TBL] [Abstract] [Full Text] [Related]
4. Clinical and Laboratory Characteristics of IgM Primary Plasma Cell Leukemia.
Wu Y; Zhang X; Ma X; Suo X; Li R
Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436385
[TBL] [Abstract] [Full Text] [Related]
5. Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas.
Gao X; Kady N; Wang C; Abdelrahman S; Gann P; Sverdlov M; Wolfe A; Brown N; Reneau J; Robida AM; Murga-Zamalloa C; Wilcox RA
Cancer Res Commun; 2022 Dec; 2(12):1727-1737. PubMed ID: 36970721
[TBL] [Abstract] [Full Text] [Related]
6. Knockdown of let-7b in leukemia associated macrophages inhibit acute myeloid leukemia progression.
Tian C; Li Y; Si J; Kang J; Chen Z; Nuermaimaiti R; Wang Y; Yu Y; Zhao Z; Wang X; Zhang Y; Zhao H; Yang H; You MJ; Zheng G; Wang L
Hematol Oncol; 2023 Aug; 41(3):510-519. PubMed ID: 36579468
[TBL] [Abstract] [Full Text] [Related]
7. Sacrococcygeal teratoma: evaluation of its approach, treatment and follow-up in two reference children cancer centers in Brazil / Rio de Janeiro.
Santos VDN; Coelho SO; Vieira AA
Rev Col Bras Cir; 2022; 49():e20223341. PubMed ID: 36074393
[TBL] [Abstract] [Full Text] [Related]
8. Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma.
Liu J; Gao T; Tan Z; Li S; Xu J; Bai C; Xue R; Xie L; Zhang L; Fan Z; Guo W
Clin Cancer Res; 2022 Aug; 28(16):3473-3479. PubMed ID: 35675031
[TBL] [Abstract] [Full Text] [Related]
9. Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experience from an HBV endemic area.
Wu Y; Chen Y; Zhu P; Ye B; Lu Y; Shi J; Tan Y; Zhao Y; Yu J; Lai X; Lan J; Si T; Ni L; Huang H; Luo Y
Ann Hematol; 2022 Mar; 101(3):631-641. PubMed ID: 34981143
[TBL] [Abstract] [Full Text] [Related]
10. Tuberous sclerosis complex misdiagnosed as multiple metastases in a cervical cancer patient: case report and literature review.
Ye T; Feng L; Peng M; Yuan S; Chen Y; Liu X; Chen J
Ann Palliat Med; 2021 Oct; 10(10):11232-11238. PubMed ID: 34763482
[TBL] [Abstract] [Full Text] [Related]
11. 18F-FDG Positron Emission Tomography/Computed Tomography (PET/CT) for Distinguishing Tuberous Sclerosis Complex Lesions from Colon cancer Metastases.
Mazurek A; Dziuk M; Witkowska-Patena E; Gizewska A; Piszczek S
Am J Case Rep; 2021 Oct; 22():e933320. PubMed ID: 34618793
[TBL] [Abstract] [Full Text] [Related]
12. Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations.
Northrup H; Aronow ME; Bebin EM; Bissler J; Darling TN; de Vries PJ; Frost MD; Fuchs Z; Gosnell ES; Gupta N; Jansen AC; Jóźwiak S; Kingswood JC; Knilans TK; McCormack FX; Pounders A; Roberds SL; Rodriguez-Buritica DF; Roth J; Sampson JR; Sparagana S; Thiele EA; Weiner HL; Wheless JW; Towbin AJ; Krueger DA;
Pediatr Neurol; 2021 Oct; 123():50-66. PubMed ID: 34399110
[TBL] [Abstract] [Full Text] [Related]
13. Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA).
Sauter M; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; de Vries PJ; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen A; Kingswood JC;
Orphanet J Rare Dis; 2021 Jul; 16(1):301. PubMed ID: 34229737
[TBL] [Abstract] [Full Text] [Related]
14. A Bama miniature pig model of monoallelic tsc1 mutation for human tuberous sclerosis complex.
Li X; Hu T; Liu J; Fang B; Geng X; Xiong Q; Zhang L; Jin Y; Liu X; Li L; Wang Y; Li R; Bai X; Yang H; Dai Y
J Genet Genomics; 2020 Dec; 47(12):735-742. PubMed ID: 33612456
[TBL] [Abstract] [Full Text] [Related]
15. Lymphangioleiomyomatosis Association with Underlying Genotype in Patients with Tuberous Sclerosis Complex.
Tian X; Glass JE; Kwiatkowski DJ; Towbin AJ; Li Y; Sund KL; Krueger DA; Franz DN; McCormack FX; Gupta N
Ann Am Thorac Soc; 2021 May; 18(5):815-819. PubMed ID: 33171065
[No Abstract] [Full Text] [Related]
16. Fibroma-like perivascular epithelioid cell tumor: a rare case in a long bone.
Ramezanpour S; Horvai AE; Zimel M; Bucknor M; Link TM
Skeletal Radiol; 2021 Apr; 50(4):821-825. PubMed ID: 32944815
[TBL] [Abstract] [Full Text] [Related]
17. lam-003, a new drug for treatment of tyrosine kinase inhibitor-resistant FLT3-ITD-positive AML.
Beeharry N; Landrette S; Gayle S; Hernandez M; Grotzke JE; Young PR; Beckett P; Zhang X; Carter BZ; Andreeff M; Halene S; Xu T; Rothberg J; Lichenstein H
Blood Adv; 2019 Nov; 3(22):3661-3673. PubMed ID: 31751472
[TBL] [Abstract] [Full Text] [Related]
18. Tibial perivascular epithelioid cell tumour (PEComa). A case report and literature review.
Técualt-Gómez R; Atencio-Chan A; Amaya-Zepeda RA; Cario-Méndez AG; González-Valladares R; Rodríguez-Franco JH
Rev Esp Cir Ortop Traumatol (Engl Ed); 2019; 63(3):239-245. PubMed ID: 30905544
[TBL] [Abstract] [Full Text] [Related]
19.
Kaur V; Kumar M; Kumar A; Kaur S
Drug Chem Toxicol; 2020 Jul; 43(4):398-408. PubMed ID: 30293450
[No Abstract] [Full Text] [Related]
20. Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab.
Zappulo E; Nicolini LA; Di Grazia C; Dominietto A; Lamparelli T; Gualandi F; Caligiuri P; Bruzzone B; Angelucci E; Viscoli C; Mikulska M
Infection; 2019 Feb; 47(1):59-65. PubMed ID: 30232604
[TBL] [Abstract] [Full Text] [Related]
[Next]
